Multicenter Study Evaluating the Role of Enterococci in Secondary Bacterial Peritonitis

被引:28
作者
Cercenado, Emilia [2 ]
Torroba, Luis [3 ]
Canton, Rafael [4 ]
Martinez-Martinez, Luis [5 ]
Chaves, Fernando [6 ]
Angel Garcia-Rodriguez, Jose [7 ]
Lopez-Garcia, Carmen [8 ]
Aguilar, Lorenzo [1 ]
Garcia-Rey, Cesar [9 ]
Garcia-Escribano, Nuria [9 ]
Bouza, Emilio [2 ]
机构
[1] Univ Complutense, Dept Microbiol, Sch Med, Madrid 28040, Spain
[2] Univ Gregorio Maranon, Gen Hosp, Dept Microbiol, Madrid 28007, Spain
[3] Hosp Virgen Camino, Dept Microbiol, Pamplona 31008, Spain
[4] Hosp Univ Ramon y Cajal, Dept Microbiol, Madrid 28034, Spain
[5] Hosp Univ Marques Valdecilla, Dept Microbiol, Santander 39008, Spain
[6] Hosp 12 Octubre, Dept Microbiol, E-28041 Madrid, Spain
[7] Univ Salamanca, Hosp Clin, Dept Microbiol, E-37008 Salamanca, Spain
[8] Hosp Univ Puerta del Mar, Dept Microbiol, Cadiz 11009, Spain
[9] Wyeth Farma SA, Dept Med, Madrid, Spain
关键词
INFECTIONS; THERAPY; EPIDEMIOLOGY; MANAGEMENT; APACHE;
D O I
10.1128/JCM.01782-09
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A 1-year prospective multicenter study was performed to explore the significance of the presence of enterococci in cultures of peritoneal fluid from patients with secondary bacterial peritonitis in seven Spanish hospitals. The clinical records of patients with positive peritoneal fluid cultures were reviewed and distributed into cases (patients with cultures yielding enterococci) and controls (patients with cultures not yielding enterococci). Of a total of 158 records, 38 (24.1%) were cases and 120 (75.9%) were controls. The percentages or the scores (cases versus controls) for the variables included in the multivariate analysis were as follows: age of >50 years, 89.5% versus 68.3%; malignancy, 39.5% versus 18.3%; chronic obstructive pulmonary disease (COPD), 15.8% versus 4.2%; postoperative peritonitis, 55.3% versus 30.1%; nosocomial onset, 57.9% versus 34.2%; a higher Charlson comorbidity index, 3.29 +/- 3.38 versus 1.84 +/- 2.31; APACHE II score, 10.71 +/- 4.37 versus 8.76 +/- 5.49; ultimately or rapidly fatal disease, 63.2% versus 34.8%; need for surgical reintervention, 36.1% versus 15.1%; and admission to an intensive care unit, 45.9% versus 30.8%. In the multivariate analysis, enterococci were associated only with postoperative peritonitis (P = 0.009; odds ratio [OR] = 5.0; 95% confidence interval [CI] = 1.49 to 16.80), a higher Charlson comorbidity index (P = 0.002; OR = 1.30; 95% CI = 1.11 to 1.54), and COPD (P = 0.046; OR = 6.50; 95% CI = 1.04 to 40.73). The results of this study showed that enterococci were associated with comorbidity. An association with mortality could not be demonstrated.
引用
收藏
页码:456 / 459
页数:4
相关论文
共 24 条
[1]  
Aronson Wendy L, 2003, AANA J, V71, P265
[2]   Prognostic scoring systems to predict outcome in peritonitis and intra-abdominal sepsis [J].
Bosscha, K ;
Reijnders, K ;
Hulstaert, PF ;
Algra, A ;
vanderWerken, C .
BRITISH JOURNAL OF SURGERY, 1997, 84 (11) :1532-1534
[3]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[4]   Empiric therapy for secondary peritonitis: A pharmacodynamic analysis of cefepime, ceftazidime, ceftriaxone, imipenem, levofloxacin, piperacillin/tazobactam, and tigecycline using Monte Carlo simulation [J].
Eagye, Kathryn J. ;
Kuti, Joseph L. ;
Dowzicky, Michael ;
Nicolau, David P. .
CLINICAL THERAPEUTICS, 2007, 29 (05) :889-899
[5]   The ecology, epidemiology and virulence of Enterococcus [J].
Fisher, Katie ;
Phillips, Carol .
MICROBIOLOGY-SGM, 2009, 155 :1749-1757
[6]   Epidemiology, Management, and Prognosis of Secondary Non-Postoperative Peritonitis: A French Prospective Observational Multicenter Study [J].
Gauzit, Remy ;
Pean, Yves ;
Barth, Xavier ;
Mistretta, Frederic ;
Lalaude, Olivier .
SURGICAL INFECTIONS, 2009, 10 (02) :119-127
[7]   Nosocomial enterococcal blood stream infections in the SCOPE program: Antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy [J].
Jones, RN ;
Marshall, SA ;
Pfaller, MA ;
Wilke, WW ;
Hollis, RJ ;
Erwin, ME ;
Edmond, MB ;
Wenzel, RP ;
Tomasulo, M ;
Williams, C ;
Word, J ;
Cavalieri, S ;
Lorenzen, A ;
Koga, D ;
Wardell, P ;
Baltzer, R ;
Ziemann, S ;
Seth, VK ;
Bourbeau, P ;
Dahlman, M ;
Moore, J ;
Sharp, S ;
Johnson, P ;
Stone, J ;
McNally, M ;
Shapiro, M ;
Tjoelker, R ;
Sewell, D ;
Davenport, ML ;
Grout, C ;
Docken, L ;
Ohrt, D ;
Anderson, D ;
Leong, D ;
Oczki, V ;
Pullen, G ;
Chapman, J ;
Gamble, S ;
DellaLatta, P ;
Fracaro, M ;
Ferwerda, H ;
Otal, T ;
Hernandez, S ;
Herwaldt, L ;
Block, J ;
Meyer, L ;
Temme, L ;
Skates, S ;
Bingham, J ;
Leslie, V .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1997, 29 (02) :95-102
[8]   APACHE - ACUTE PHYSIOLOGY AND CHRONIC HEALTH EVALUATION - A PHYSIOLOGICALLY BASED CLASSIFICATION-SYSTEM [J].
KNAUS, WA ;
ZIMMERMAN, JE ;
WAGNER, DP ;
DRAPER, EA ;
LAWRENCE, DE .
CRITICAL CARE MEDICINE, 1981, 9 (08) :591-597
[9]   APACHE-II - A SEVERITY OF DISEASE CLASSIFICATION-SYSTEM [J].
KNAUS, WA ;
DRAPER, EA ;
WAGNER, DP ;
ZIMMERMAN, JE .
CRITICAL CARE MEDICINE, 1985, 13 (10) :818-829
[10]   Enterococcal infections: host response, therapeutic, and prophylactic possibilities [J].
Koch, S ;
Hufnagel, M ;
Theilacker, C ;
Huebner, J .
VACCINE, 2004, 22 (07) :822-830